A new therapy, recently granted a UK Innovation Passport Designation, could help to improve treatment outcomes for Krabbe disease patients post-stem cell transplant. What is Krabbe disease? Krabbe disease is a rare genetic disorder affecting around 1 in every...
Advancements in stem cell research are transforming how we approach some of the most critical health conditions. One particularly exciting area is the use of umbilical cord stem cells in treating acute liver failure (ALF). ALF is a life-threatening condition with...
A new clinical trial investigating the use of umbilical cord stem cells to treat chronic heart failure is currently underway. The Phase II trial, which is the first of its kind in the U.S., is being carried out by researchers at the University of Louisville. It’s also...
Last week it was announced that a new gene editing stem cell therapy for beta thalassemia would start to be made available on the NHS. The therapy, called Casgevy, is developed by Vertex Pharmaceuticals and CRISPR Therapeutics and received approval from the UK...
Emerging research suggests that stem cell-based therapies could offer a new approach to treating influenza-related lung damage. Mesenchymal stem cells (MSCs) in particular have been shown to repair lung tissue and modulate the immune response, providing hope for...
The results from a Phase I/II clinical trial suggests a new stem cell-based therapy has the power to treat osteoarthritis (OA). The trial, which was conducted by Australian biotechnology company Magellan Stem Cells, demonstrated that their ‘off-the-shelf’ stem cell...
